We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Simultaneous Detection and Quantification of Different miRNAs

By HospiMedica staff writers
Posted on 17 May 2007
A unique solution allows for the sensitive, specific, and simultaneous detection and quantification of hundreds of different micro (mi)RNAs as well as other RNAs (e.g., messenger or mRNA).

The newly launched miScript product line incorporates a technology that for the first time enables researchers to identify multiple miRNAs from one single complementary cDNA reaction in a given biologic sample. More...
cDNA is a synthesized copy of the RNA that is widely used for polymerase chain reaction (PCR)-based target detection in molecular diagnostics, biomedical, and pharmaceutical research.

miRNAs are a newly discovered class of RNA molecules that have been found to play a significant role in the regulation of gene expression. Recent discoveries indicate that miRNAs can correlate with cancer and other diseases, sparking significant interest in today's life science and molecular diagnostics research. Despite the significant importance of this new class of RNA molecules, current methods for the isolation, identification, and quantification of the presence of miRNA in biologic samples are often cumbersome and imprecise.

Together with Qiagen's (Hamburg, Germany) other sample and assay technologies products for miRNA such as with Qiagen's miRNeasy kits, the new Qiagen miScript system forms an integrated and comprehensive system for the isolation and detection of miRNAs in hundreds of assays, which are available for the human, mouse, and rat genome.


Related Links:
Qiagen

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Vessel Sealing Instrument
ERGOseal
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.